![Charlotte Pahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 61 729 $ au 30/06/2026
Ms. Charlotte Pahl is on the Board of Directors at Pharma Equity Group A/S, Repoceuticals A/S and Reponex Pharmaceuticals A/S.
Ms. Pahl also served on the board at Swedish Orphan Biovitrum AB.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 4 694 210 ( 0,38% ) | 61 729 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PHARMA EQUITY GROUP A/S | Directeur/Membre du Conseil | 16/04/2025 |
Reponex Pharmaceuticals A/S
 Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Repoceuticals A/S | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Pharma Equity Group A/S
 Pharma Equity Group A/S Pharmaceuticals: MajorHealth Technology Functions as an investment holding company whose subsidiary develops bacterial peritonitis, chronic skin ulcers, inflammatory bowel and cancer biopharmaceuticals | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Reponex Pharmaceuticals A/S
Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Repoceuticals A/S |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
